DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Sotiriou C, Rothé F, Maetens M. et al.
Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: results from the NeoALTTO phase III trial [abstract].
In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5–9; San Antonio, TX Philadelphia (PA): AACR
Cancer Res 2018;
78: Abstr. GS1-04
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.